Making Sense with Sam Harris - Subscriber Content

#377 - The Future of Psychedelic Medicine 2

10 snips
Jul 26, 2024
Dr. Jennifer Mitchell, a UCSF neurology expert, and Dr. Sarah Abedi, a dedicated psychedelic researcher, discuss the evolving landscape of psychedelic medicine. They explore the promising potential of MDMA-assisted therapy for PTSD and the historical context of psychedelics, tracing their tumultuous past and recent resurgence. The conversation highlights the complexities of research, ongoing FDA approval hurdles, and the ethical considerations surrounding therapeutic practices. Ultimately, they envision a future where psychedelics provide innovative solutions for mental health treatment.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

ER Revolving Door

  • Sarah Abedi's ER experience revealed a prevalence of untreated mental health issues.
  • Patients sought help but conventional treatments failed, leading her to explore psychedelics.
INSIGHT

Funding Hurdles

  • Funding for psychedelic research is limited due to the war on drugs and stigmatization.
  • Philanthropists have filled the gap but broader funding is needed.
ANECDOTE

Accidental Involvement

  • Jennifer Mitchell accidentally attended a MAPS phase three planning meeting.
  • This led to her joining their research on MDMA for PTSD.
Get the Snipd Podcast app to discover more snips from this episode
Get the app